Aridis Pharmaceuticals, Inc. (ARDS)
OTCMKTS · Delayed Price · Currency is USD
0.0031
+0.00075 (31.91%)
At close: Jun 17, 2026
Aridis Pharmaceuticals Market Cap
Aridis Pharmaceuticals has a market cap or net worth of $165.3 thousand as of June 18, 2026. Its market cap has increased by 311,777.36% in one year.
Market Cap
165.30K
Enterprise Value
n/a
Revenue
22.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 14, 2018, Aridis Pharmaceuticals's market cap has decreased from 102.57M to 165.30K, a decrease of -99.84%. That is a compound annual growth rate of -55.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 165.30K | 106.67% |
| Dec 31, 2025 | 79.98K | 1,400.02% |
| Dec 31, 2024 | 5.33K | -99.83% |
| Dec 29, 2023 | 3.18M | -89.17% |
| Dec 30, 2022 | 29.39M | -10.24% |
| Dec 31, 2021 | 32.75M | -46.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovation Pharmaceuticals | 211.51K |
| Ampio Pharmaceuticals | 207.88K |
| THC Farmaceuticals | 199.45K |
| Endonovo Therapeutics | 180.76K |
| GB Sciences | 158.82K |
| Immunotech Laboratories | 114.99K |
| Regen BioPharma | 112.39K |
| Synairgen | 110.27K |